04Mar
Global Private Equity Newsletter - Winter 2020 Edition: Deals in the Life Sciences Sector Article 1: Value Drivers and Risks
As the private equity industry matures, and the deal landscape becomes more competitive, private equity sponsors are becoming more prepared and capable of investing in sectors previously considered overly-regulated, requiring advanced chemistry or...
By:
Dechert LLP
Related
As employers with operations in California had feared, Governor Gavin Newsom has signed AB 51, which...
Read More >
It seems like we’ve discussed this subject for years. It was May of 2016 when the Obama DOL issued ...
Read More >
Many years ago, I represented a defined benefit plan sponsor being investigated by the Department of...
Read More >
Host Michael Schmidt is joined by Rebecca Nathanson, the Director of the Anti-Retaliation Unit and C...
Read More >
The California Consumer Privacy Act (“CCPA”) is set to take effect January 1, 2020. Since the anno...
Read More >
Brightstar Corp. v. PCS Wireless, LLC, C.A. No. N18C-10-250 PRW CCLD (Del. Super. Ct. Aug. 7, 2019)....
Read More >